Efficacy and safety of sildenafil in patients with erectile dysfunction and hypertension. Prognostic factors;Eficacia y seguridad del sildenafilo en pacientes con disfunción erétil e hipertensión arterial. Factores pronósticos de respuesta

Medicina Clinica

Volumn 119, Issue 8, 2002, Pages 281-285

  Martínez Jabaloyas, José M ^a   Gil Salom, Manuel ^a   Pastor Hernández, Francisco ^a   Villamón Fort, Rafael ^a   García Sisamón, Francisco ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Hypertension; Impotence; Prognosis; Sildenafil

Indexed keywords

GLUCOSE; HORMONE; LIPID; NITRATE; PROSTAGLANDIN E1; SILDENAFIL;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; COLOR ULTRASOUND FLOWMETRY; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NOSE CONGESTION; PENIS NOCTURNAL TUMESCENCE; PHYSICAL EXAMINATION; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RASH; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL DISORDER;

EID: 17744418497     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73390-3     Document Type: Article

References (30)

1. NIH Consensus Conference Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
2. Martín Morales A, Sánchez Cruz JJ, Saénz de Tejada I, Rodríguez Vela L, Jiménez Cruz JF, Burgos Rodríguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la disfunción eréctil masculina study. J Urol 2001;166: 569-75.
3. Feldman H, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachussetts Male Aging Study. J Urol 1994;151: 54-61.
4. Compañ Barco L, Vioque J, Quiles J, Hernández-Aguado I, Borras F. Prevalencia y control de la hipertensión arterial en la población adulta de la Comunidad Valenciana, 1994. Med Clin (Barc) 1998;110:328-33.
5. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995;22: 699-709.
6. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000;164:1188-91.
7. Price D. Sildenafil citrate (Viagra) efficacy in the treatment of erectile dysfunction in patients with common concomitant conditions. Sildenafil Study Group. Int J Clin Pract Suppl 1999;102: 21-3.
8. Junemann KP. Pharmacotesting in erectile dysfunction. En: Jonas U, editor. Erectile dysfunction. Berlin; Springer Verlag, 1991; p. 104-14.
9. Rosen RC, Leiblum SR, Spector I. Psychologically based treatment for male erectile disorder: a cognitive-interpersonal model. J Sex Marital Ther 1994;20:67-85.
10. Sadovsky R, Miller T, Moskowitz M, Hackett G. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract 2000;55: 115-28.
11. Steers WD. Viagra-after one year. Urology 1999;54:12-7.
12. Virag R. Indication and early results of sildenafil (Viagra) in erectil dysfunction. Urology. 1999; 54:1073.
13. Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999;162: 722.
14. Giuliano F, Montorsi F, Mirone V, Rossi D, Sweeney M. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunciton: results of a multicenter european study. J Urol 2000;164: 708-11.
15. McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000;164:1192-6.
16. Palumbo F, Bettochi C, Selvaggi FP, Prior JP, Ralph DJ. Sildenafil: efficacy and safety in daily clinical experience. Eur Urol 2001;40: 176-80.
17. Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001,14:70-3.
18. Guay AT, Pérez JB, Jacobson J, Newton RA. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001; 22:793-7.
19. Olsson AM, Persson CA, Swedish Sildenafil Investigators Group. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease. Int J Clin Pract 2001;55:171-6.
20. Shabsigh R. Efficacy of sildenafil citrate (VIAGRA) is not affected by aetiology of erectile dysfunction. In J Clin Pract Suppl 1999;102:19-20.
21. Rendell MS, Rajfer J, Wicker PA, Smith MD, for the Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. JAMA 1999;281:421-6.
22. Bemelmans BL, Meuleman EJ, Doesburg WH, Notermans SL, Debruyne FM. Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 1994;151:884-9.
23. Steers WD. Meta-analysis of the efficacy of sildenafil in the treatment of severe erectile dysfunction. J Urol 1998;159(Suppl):238.
24. Hatzichristou DG, Apostolidis A, Tzortzis V, Ioanides E, Yannakoyorgos K, Kalinderis A. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 2000;164: 1197-200.
25. Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001;28:321-34.
26. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999;83:29C-34C.
27. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectil dysfunction. Int J Impotence Res 1998;10:69-74.
28. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000,342:1622-6.
29. Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. BMJ 2001;322:651-2.
30. Cohen JS. Sildenafil and nonnitrate antihypertensive medications. JAMA. 2000;283:201-2.